GRDN | tickerfilter.com

Fundamental analysis

59%

Profitability 70%

Dept financing 33%

Liquidity 35%

Performance 60%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

3.27%

1 Month

5.75%

3 Months

16.80%

6 Months

23.22%

1 Year

77.98%

2 Year

117.25%

Key data

Stock price

$34.76

P/E Ratio

41.35

DAY RANGE

$33.43 - $35.15

EPS

-$1.69

52 WEEK RANGE

$17.78 - $37.43

52 WEEK CHANGE

$89.74

MARKET CAP

1.664 B

YIELD

N/A

SHARES OUTSTANDING

63.321 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

05-15-2025

BETA

2.19

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$158,427

AVERAGE 30 VOLUME

$176,969

Company detail

CEO: Fred P. Burke
Region: US
Website: guardianpharmacy.com
Employees: 0
IPO year: 2024

Issue type:
Market: NYSE
Industry: Retail/Retail – Drug & Proprietary Stores
Sector: Retail Trade

We are a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of long-term health care facilities (“LTCFs”) adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. Our principal executive offices are located at 300 Galleria Parkway SE, Suite 800, Atlanta, Georgia.

GRDN - Guardian Pharmacy Services, Inc.